⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 3, 2014Journal of Inherited Metabolic Disease

Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta‐analysis

View Full Paper

Ask AI

Bookmark

Share

Abstract

ERT is effective in reducing LVH, but has a limited effect on renal function. Improved treatment options are needed for Fabry disease.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rombach et al. (2014) studied this question.

synapsesocial.com/papers/69dba13950e1971baba3c01f https://doi.org/10.1007/s10545-014-9677-8

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Improvement in serial cardiopulmonary exercise testing following enzyme replacement therapy in Fabry diseaseCohort Study · 2006 · 58 citations
2The right ventricle in Fabry disease: natural history and impact of enzyme replacement therapycohort · 2010 · 78 citations
3Agalsidase Benefits Renal Histology in Young Patients with Fabry DiseaseOriginal Research · 2012 · 237 citations
4Enzyme replacement therapy with agalsidase β improves cardiac involvement in Fabry's diseaseOriginal Research · 2004 · 116 citations
5Natural history of Fabry disease in females in the Fabry Outcome SurveySurvey · 2005 · 303 citations